Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized comparative study of CGRP monoclonal antibodies for migraine
jRCT1041230151Recruiting
- Start
- Apr 2024
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial in migraine, chronic migraine and medication overuse headache (MOH) comparing Emgality arm, Ajovy arm and Aimovig arm (3 arms). Started Apr 2024; status: recruiting.
02
Drugs
galcanezumabfremanezumaberenumab
03
Conditions
migrainechronic migrainemedication overuse headache (MOH)
Beyond the preview
Go deeper on jRCT1041230151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041230151.